Therefore, there is a need to create new appropriate mouse models for LAMA2-CMD based on human high-frequency mutated region using the latest gene editing technology, such as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9. The gene discussed is LAMA2; the disease is congenital muscular dystrophy.